Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioMimetic Therapeutics, Inc. (NASDAQ: BMTI)

Marketwired

OKLAHOMA CITY, OK--(Marketwire - 07/08/11) - On July 6, 2011 , a class action lawsuit was filed in the United States District Court for the Middle District of Tennessee against BioMimetic Therapeutics, Inc. (NASDAQ:BMTI - News). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material misrepresentations to the market which had the effect of artificially inflating the market price. The class period is from October 14, 2009 through May 11, 2011.Plaintiff seeks to recover damages on behalf of the Class. If you are a member of the Class as described above, you may move the Court no later than Tuesday, September 6, 2011, to serve as lead plaintiff for the Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.If you wish to discuss this action, participate as a potential lead plaintiff, wish to discuss any other lawsuit, or have any questions or concerns regarding this notice, or preservation of your rights, please contact:

Contact:


K. Lynn Nunn
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
(405) 235-1560
Email to: kln@federmanlaw.com
www.federmanlaw.com
View Comments (0)